139149-06-7

Basic information

• Product Name: 6-(4-methoxy-benzyloxy)-3,4-dihydro-2H-naphthalen-1-one
• Synonyms: 6-(4-methoxy-benzyloxy)-3,4-dihydro-2H-naphthalen-1-one
• CAS NO: 139149-06-7
• Molecular Weight: 282.339
• Mol File: 139149-06-7.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 6-(4-methoxy-benzyloxy)-3,4-dihydro-2H-naphthalen-1-one(CAS DataBase Reference)
• NIST Chemistry Reference: 6-(4-methoxy-benzyloxy)-3,4-dihydro-2H-naphthalen-1-one(139149-06-7)
• EPA Substance Registry System: 6-(4-methoxy-benzyloxy)-3,4-dihydro-2H-naphthalen-1-one(139149-06-7)

Safety Data

• Hazardous Substances Data: 139149-06-7(Hazardous Substances Data)

Upstream product

• 3470-50-6 6-Hydroxy-1-tetralone 
• 824-94-2 p-methoxybenzyl chloride 

Downstream Products

• 950505-23-4 (R/S)-[6-(2'-butoxy-5'-methyl-biphenyl-4-ylmethoxy)-1,2,3,4-tetrahydro-naphthalen-1-yl]-acetic acid ethyl ester 
• 950505-77-8 (R/S)-[6-((E)-2-biphenyl-4-yl-vinyl)-1,2,3,4-tetrahydro-naphthalen-1-yl]-acetic acid ethyl ester 
• 950505-78-9 (R/S)-[6-(1-biphenyl-4-yl-vinyl)-1,2,3,4-tetrahydro-naphthalen-1-yl]-acetic acid ethyl ester 
• 950505-81-4 {6-[(E)-2-(4-trifluoromethyl-phenyl)-vinyl]-1,2,3,4-tetrahydro-naphthalen-1-yl}-acetic acid ethyl ester 
• 950505-79-0 (R/S)-[6-((E)-2-biphenyl-4-yl-vinyl)-1,2,3,4-tetrahydro-naphthalen-1-yl]-acetic acid 
• 950505-27-8 difluoro-[1-hydroxy-6-(4-methoxy-benzyloxy)-1,2,3,4-tetrahydro-naphthalen-1-yl]-acetic acid ethyl ester 
• 950505-25-6 6-(4-methoxybenzyloxy)-2-methyl-3,4-dihydronaphthalen-1(2H)-one 
• 929713-42-8 [6-(4-methoxy-benzyloxy)-3,4-dihydro-2H-naphthalen-(1E)-ylidene]-acetic acid 

Relevant articles and documents

Conformationally constrained 3-(4-hydroxy-phenyl)-substituted-propanoic acids useful for treating metabolic disorders

The present invention provides compounds useful, for example, for treating metabolic disorders in a subject. Such compounds have the general formula I: where the definitions of the variables Q, L1, L2, M, X, L3, and A are provided herein. The present invention also provides compositions that include, and methods for using, the compounds in preparing medicaments and for treating metabolic disorders such as, for example, type II diabetes.